Hosted on MSN3d
Compared to Estimates, Apellis Pharmaceuticals (APLS) Q4 Earnings: A Look at Key MetricsFor the quarter ended December 2024, Apellis Pharmaceuticals, Inc. (APLS) reported revenue of $212.53 million, up 45.2% over the same period last year. EPS came in at -$0.29, compared to -$0.73 in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback